CS MEDICA A/S: Notice of Shareholders Annual Meeting
The shareholders of CS MEDICA A/S (”CS MEDICA” or the ”Company”) are hereby notified of the Annual General Meeting that will be held on Thursday December 9, 2021 at 15:00 at the offices of the Company, Fruebjergvej 3, 2100 Copenhagen, Denmark. Shareholder will be entitled to vote by submitting postal vote forms prior to the meeting. Information about the resolutions passed at the meeting will be made public December 9, 2021 after the general meeting has been held.
The registration date is 2 December 2021. Only those who are shareholders on this date have the right to participate and vote at the general meeting.
In order to obtain physical access to the general meeting and thus to be able to participate in and vote at the general meeting, a shareholder must, no later than 2 days before the general meeting, request an admission card, cf. section 5.9 of the articles of association. Such request must be made to Elisabeth Bernhardt Jensen, e-mail firstname.lastname@example.org. The request must be received no later than 7 December 2021, at 11.59 PM (CET). A shareholder has also the possibility of requesting an admission card for a proxy holder who attend the general meeting by meeting physically on behalf of the shareholder. The request must be made according to the above guidelines. The shareholder must fill in and sign the proxy and postal voting form, enclosed as schedule 1 and which also can be found on the Company's website www.cs-medica.com. The proxy must bring the admission card and the original form at the general meeting.
To be entitled to participate in the general meeting, shareholders whose shares are registered in the name of a nominee must temporarily re-register their shares in their own names in the share register. Such registration must be duly affected in the share register on 2 December 2021, and the shareholders must therefore advise their nominees well in advance of such date.
The shareholders have the right to ask questions in relation to the issues on the agenda to be discussed at the general meeting. The questions can be made in writing before the general meeting or at the general meeting. The answer will - with the limitations that follow from the legislation - if possible be made at the general meeting or be made available to the shareholders no later than two weeks after the general meeting.
All material mentioned in this notice can be obtained from Elisabeth Bernhardt Jensen, e-mail email@example.com. The material will only be forwarded by e-mail, and thus the e-mail address must be specified.
- Election of chairman of the meeting.
- Presentation of the annual report with auditors’ report for adoption.
- Resolution concerning the appropriation of profits as recorded in the adopted annual report.
- Election of members to the board of directors.
- Election of the Company’s auditor.
- Change of the Company’s signatory rule
- Change of clause 5.9 in the articles of association
- Any other business.
The total number of votes as of the date of this notice is 10,902,000.
2. Presentation of the annual report with auditors’ report for adoption.
The annual report as approved by the board of directors will be presented to the general meeting for approval.
3. Resolution concerning the appropriation of profits or losses as recorded in the adopted annual report.
The board of directors proposes that the result for the period 1 October 2020 – 30 September 2021 (DKK 647,626) is carried forward to the following year.
5. Election of auditor.
The board of directors proposes that the existing auditor (Christensen Kjærulff Statsautoriseret Revisionsaktieselskab) is re-elected.
6. Change of the Company’s signatory rule.
The board of directors proposes that the signatory rule in clause 8.1 of the articles of association is changed from:
“The Company is bound by the joint signatures of the CEO and the chairman, by four members of the board of directors or by the chairman and two members of the board of directors.”
“The Company is bound by the joint signatures of the CEO and one member of the board of directors, by three members of the board of directors or by the entire board of directors.”
7. Change of clause 5.9 in the articles of assocation.
The board of directors proposes that ”VP Investor Services A/S” is changed to the “Company” in clause 5.9 in the articles of association, whereupon clause 5.9 reads:
“Any shareholder who has requested an admission card no later than two days before the general meeting or has sent an instrument appointing a proxy so that it is received by the Company no later than two days before the general meeting will be entitled to attend the meeting. Shareholders unable to attend may vote by postal ballot. The postal ballot must be received by the Company no later than 4.00 pm on the day before the general meeting.”
CS MEDICA A/S
On behalf of the board of directors
Jørgen Flemming Ladefoged, chairman
This disclosure contains information that CS MEDICA A/S is obliged to make public pursuant to the Swedish Securities Markets Act (2007:528) and the Swedish Financial Instruments Trading Act (1991:980). The information was submitted for publication, through the agency of the contact person, on 25-11-2021 09:54 CET.
For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.